Primary study · included by 1 review

Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.

Xu 2022 · Xu Zhihong, Li Xiaodong, Pan Lanlan, et al. · Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2022

Included by

Computational Stemness and Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma: A Systematic Review, Dual Meta-Analysis, and Functional Meta-Synthesis.

Non-Cochrane · prognostic · 2025 · cited as Xu 2022 · Table 1; References

Outcome this study informs	Pooled effect	Evidence	Certainty
Overall survival High computational stemness signature or risk score (mRNAsi, lncRNA, multigene, CpG signatures) vs Low stemness signature or risk score	HR 2.24 [1.61, 3.12]	6 studies	Moderate
Overall survival High computational stemness signature or risk score (mRNAsi, lncRNA, multigene, CpG signatures) vs Low stemness signature or risk score	HR 2.13 [1.56, 2.89]	5 studies	GRADE not reported

1 including review in total.